DR. JAMES W LEVINE DO NPI 1093793838

NPI Details

DR. James W Levine, DO is a rheumatology internal medicine in Greeley, CO with 27 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. James W Levine, DO NPI is 1093793838. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MIDWESTERN UNIVERSITY, CHICAGO COLLEGE OF OSTEOPATHIC MED
Graduation Year:1998

The provider's business location address is:

1675 18TH AVE
SUITE 3
GREELEY, CO
ZIP 80631-132
Phone: (970) 350-2433
Fax: (970) 392-4768

The NPI 1093793838 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg (HCPCS:Q5103)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Hyaluronan or derivative, monovisc, for intra-articular injection, per dose (HCPCS:J7327)

The enumeration date for this NPI number is 1/3/2006 and was last updated on 8/31/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.